annual cash & cash equivalents:
$2.22B+$934.00M(+72.74%)Summary
- As of today (May 29, 2025), MDT annual cash & cash equivalents is $2.22 billion, with the most recent change of +$934.00 million (+72.74%) on April 1, 2025.
- During the last 3 years, MDT annual cash & cash equivalents has fallen by -$1.50 billion (-40.28%).
- MDT annual cash & cash equivalents is now -55.35% below its all-time high of $4.97 billion, reached on April 28, 2017.
Performance
MDT Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$2.22B+$978.00M(+78.87%)Summary
- As of today (May 29, 2025), MDT quarterly cash & cash equivalents is $2.22 billion, with the most recent change of +$978.00 million (+78.87%) on April 1, 2025.
- Over the past year, MDT quarterly cash & cash equivalents has increased by +$934.00 million (+72.74%).
- MDT quarterly cash & cash equivalents is now -87.13% below its all-time high of $17.23 billion, reached on January 31, 2015.
Performance
MDT quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
MDT Cash and cash equivalents Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +72.7% | +72.7% |
3 y3 years | -40.3% | -40.3% |
5 y5 years | -46.4% | -46.4% |
MDT Cash and cash equivalents Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -40.3% | +72.7% | -54.1% | +78.9% |
5 y | 5-year | -46.4% | +72.7% | -65.9% | +78.9% |
alltime | all time | -55.4% | +6027.1% | -87.1% | +8916.3% |
MDT Cash and cash equivalents History
Date | Annual | Quarterly |
---|---|---|
Apr 2025 | $2.22B(+72.7%) | $2.22B(+78.9%) |
Jan 2025 | - | $1.24B(-11.0%) |
Oct 2024 | - | $1.39B(+6.3%) |
Jul 2024 | - | $1.31B(+2.1%) |
Apr 2024 | $1.28B(-16.8%) | $1.28B(-20.9%) |
Jan 2024 | - | $1.62B(+23.8%) |
Oct 2023 | - | $1.31B(-2.1%) |
Jul 2023 | - | $1.34B(-13.2%) |
Apr 2023 | - | $1.54B(-65.9%) |
Apr 2023 | $1.54B(-58.5%) | - |
Jan 2023 | - | $4.52B(-6.4%) |
Oct 2022 | - | $4.83B(+125.6%) |
Jul 2022 | - | $2.14B(-42.4%) |
Apr 2022 | $3.71B(+3.4%) | $3.71B(+6.8%) |
Jan 2022 | - | $3.48B(+20.0%) |
Oct 2021 | - | $2.90B(-3.5%) |
Jul 2021 | - | $3.00B(-16.4%) |
Apr 2021 | $3.59B(-13.2%) | $3.59B(-29.2%) |
Jan 2021 | - | $5.08B(-20.9%) |
Oct 2020 | - | $6.42B(-1.2%) |
Jul 2020 | - | $6.50B(+57.0%) |
Apr 2020 | $4.14B(-5.8%) | $4.14B(+11.6%) |
Jan 2020 | - | $3.71B(-6.4%) |
Oct 2019 | - | $3.96B(-22.0%) |
Jul 2019 | - | $5.08B(+15.6%) |
Apr 2019 | $4.39B(+19.7%) | $4.39B(+18.6%) |
Jan 2019 | - | $3.70B(-5.3%) |
Oct 2018 | - | $3.91B(-10.7%) |
Jul 2018 | - | $4.38B(+19.4%) |
Apr 2018 | $3.67B(-26.1%) | $3.67B(-42.3%) |
Jan 2018 | - | $6.36B(+15.0%) |
Oct 2017 | - | $5.53B(+17.9%) |
Jul 2017 | - | $4.69B(-5.6%) |
Apr 2017 | $4.97B(+72.7%) | $4.97B(+79.4%) |
Jan 2017 | - | $2.77B(-6.3%) |
Oct 2016 | - | $2.95B(-3.5%) |
Jul 2016 | - | $3.06B(+6.4%) |
Apr 2016 | $2.88B(-40.6%) | $2.88B(+5.7%) |
Jan 2016 | - | $2.72B(+14.4%) |
Oct 2015 | - | $2.38B(-20.2%) |
Jul 2015 | - | $2.98B(-38.5%) |
Apr 2015 | $4.84B(+245.2%) | $4.84B(-71.9%) |
Jan 2015 | - | $17.23B(+1238.9%) |
Oct 2014 | - | $1.29B(-3.7%) |
Jul 2014 | - | $1.34B(-4.8%) |
Apr 2014 | $1.40B(+52.7%) | $1.40B(+7.6%) |
Jan 2014 | - | $1.30B(+22.3%) |
Oct 2013 | - | $1.07B(+28.7%) |
Jul 2013 | - | $828.00M(-9.9%) |
Apr 2013 | $919.00M(-21.6%) | $919.00M(-29.2%) |
Jan 2013 | - | $1.30B(-26.2%) |
Oct 2012 | - | $1.76B(+104.3%) |
Jul 2012 | - | $861.00M(-26.5%) |
Apr 2012 | $1.17B(-15.2%) | $1.17B(-1.5%) |
Jan 2012 | - | $1.19B(+13.5%) |
Oct 2011 | - | $1.05B(-24.8%) |
Jul 2011 | - | $1.39B(+0.8%) |
Apr 2011 | $1.38B(-1.3%) | $1.38B(+7.7%) |
Jan 2011 | - | $1.28B(+2.1%) |
Oct 2010 | - | $1.26B(-7.9%) |
Jul 2010 | - | $1.36B(-2.6%) |
Apr 2010 | $1.40B(+10.1%) | $1.40B(-4.3%) |
Jan 2010 | - | $1.46B(+77.1%) |
Oct 2009 | - | $826.00M(-19.2%) |
Jul 2009 | - | $1.02B(-19.6%) |
Apr 2009 | $1.27B(+19.9%) | $1.27B(-0.9%) |
Jan 2009 | - | $1.28B(+137.2%) |
Oct 2008 | - | $541.00M(-53.8%) |
Jul 2008 | - | $1.17B(+10.4%) |
Apr 2008 | $1.06B(-15.6%) | $1.06B(+45.4%) |
Jan 2008 | - | $729.00M(-84.4%) |
Oct 2007 | - | $4.68B(+436.4%) |
Jul 2007 | - | $873.00M(-30.5%) |
Apr 2007 | $1.26B | $1.26B(-39.8%) |
Jan 2007 | - | $2.09B(+91.5%) |
Date | Annual | Quarterly |
---|---|---|
Oct 2006 | - | $1.09B(-21.9%) |
Jul 2006 | - | $1.40B(-53.4%) |
Apr 2006 | $2.99B(+34.1%) | $2.99B(+118.9%) |
Jan 2006 | - | $1.37B(-29.8%) |
Oct 2005 | - | $1.95B(+22.5%) |
Jul 2005 | - | $1.59B(-28.8%) |
Apr 2005 | $2.23B(+40.1%) | $2.23B(+2.1%) |
Jan 2005 | - | $2.19B(-4.9%) |
Oct 2004 | - | $2.30B(+6.8%) |
Jul 2004 | - | $2.15B(+35.0%) |
Apr 2004 | $1.59B(+8.4%) | $1.59B(+25.7%) |
Jan 2004 | - | $1.27B(+30.5%) |
Oct 2003 | - | $971.00M(-17.2%) |
Jul 2003 | - | $1.17B(-20.2%) |
Apr 2003 | $1.47B(+257.9%) | $1.47B(+0.1%) |
Jan 2003 | - | $1.47B(+48.2%) |
Oct 2002 | - | $990.90M(+13.6%) |
Jul 2002 | - | $872.10M(+112.3%) |
Apr 2002 | $410.70M(-60.1%) | $410.70M(-10.5%) |
Jan 2002 | - | $458.80M(+62.1%) |
Oct 2001 | - | $283.10M(-75.8%) |
Jul 2001 | - | $1.17B(+13.6%) |
Apr 2001 | $1.03B(+120.2%) | $1.03B(+129.6%) |
Jan 2001 | - | $448.80M(-23.6%) |
Oct 2000 | - | $587.50M(+2.1%) |
Jul 2000 | - | $575.20M(+23.0%) |
Apr 2000 | $467.80M(+104.7%) | $467.80M(+202.2%) |
Jan 2000 | - | $154.80M(-1.9%) |
Oct 1999 | - | $157.80M(-31.4%) |
Jul 1999 | - | $230.00M(+0.7%) |
Apr 1999 | $228.50M(-56.0%) | $228.50M(-34.1%) |
Jan 1999 | - | $346.60M(-39.4%) |
Oct 1998 | - | $572.30M(+120.8%) |
Jul 1998 | - | $259.20M(-50.1%) |
Apr 1998 | $519.50M(+163.2%) | $519.50M(+67.3%) |
Jan 1998 | - | $310.60M(+4.3%) |
Oct 1997 | - | $297.90M(+6.3%) |
Jul 1997 | - | $280.20M(+41.9%) |
Apr 1997 | $197.40M(+79.0%) | $197.40M(+223.1%) |
Jan 1997 | - | $61.10M(-31.3%) |
Oct 1996 | - | $89.00M(-26.5%) |
Jul 1996 | - | $121.10M(+9.8%) |
Apr 1996 | $110.30M(+12.2%) | $110.30M(-8.2%) |
Jan 1996 | - | $120.10M(-3.4%) |
Oct 1995 | - | $124.30M(-12.2%) |
Jul 1995 | - | $141.60M(+44.0%) |
Apr 1995 | $98.30M(-9.6%) | $98.30M(-24.0%) |
Jan 1995 | - | $129.30M(+12.4%) |
Oct 1994 | - | $115.00M(+49.4%) |
Jul 1994 | - | $77.00M(-29.2%) |
Apr 1994 | $108.70M(+41.2%) | $108.70M(-8.7%) |
Jan 1994 | - | $119.00M(+104.8%) |
Oct 1993 | - | $58.10M(-14.3%) |
Jul 1993 | - | $67.80M(-11.9%) |
Apr 1993 | $77.00M(-23.6%) | $77.00M(-46.3%) |
Jan 1993 | - | $143.50M(+6.1%) |
Oct 1992 | - | $135.20M(+102.4%) |
Jul 1992 | - | $66.80M(-33.7%) |
Apr 1992 | $100.80M(+13.5%) | $100.80M(+18.4%) |
Jan 1992 | - | $85.10M(+28.7%) |
Oct 1991 | - | $66.10M(-0.8%) |
Jul 1991 | - | $66.60M(-25.0%) |
Apr 1991 | $88.80M(+145.3%) | $88.80M(+24.5%) |
Jan 1991 | - | $71.30M(+23.6%) |
Oct 1990 | - | $57.70M(+3.2%) |
Jul 1990 | - | $55.90M(+54.4%) |
Apr 1990 | $36.20M(-29.4%) | $36.20M(+47.2%) |
Jan 1990 | - | $24.60M(-15.8%) |
Oct 1989 | - | $29.20M(-43.1%) |
Apr 1989 | $51.30M(-34.6%) | $51.30M(-34.6%) |
Apr 1988 | $78.50M(-31.0%) | $78.50M(-31.0%) |
Apr 1987 | $113.70M(-16.0%) | $113.70M(-16.0%) |
Apr 1986 | $135.40M(-1.2%) | $135.40M(-1.2%) |
Apr 1985 | $137.10M(+17.7%) | $137.10M(+17.7%) |
Apr 1984 | $116.50M | $116.50M |
FAQ
- What is Medtronic annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Medtronic?
- What is Medtronic annual cash & cash equivalents year-on-year change?
- What is Medtronic quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Medtronic?
- What is Medtronic quarterly cash & cash equivalents year-on-year change?
What is Medtronic annual cash & cash equivalents?
The current annual cash & cash equivalents of MDT is $2.22B
What is the all time high annual cash & cash equivalents for Medtronic?
Medtronic all-time high annual cash & cash equivalents is $4.97B
What is Medtronic annual cash & cash equivalents year-on-year change?
Over the past year, MDT annual cash & cash equivalents has changed by +$934.00M (+72.74%)
What is Medtronic quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of MDT is $2.22B
What is the all time high quarterly cash & cash equivalents for Medtronic?
Medtronic all-time high quarterly cash & cash equivalents is $17.23B
What is Medtronic quarterly cash & cash equivalents year-on-year change?
Over the past year, MDT quarterly cash & cash equivalents has changed by +$934.00M (+72.74%)